Here are six takeaways:
1. Barclays issued an “underweight” rating and a $107.00 price target on the company’s stock.
2. Stryker stock presently has a consensus rating of “hold” and a consensus price target of $102.14.
3. The company’s 50-day moving average is $104.43 and its 200-day moving average is $97.59.
4. Stryker has a 12-month low of $86.68 and a 12-month high of $109.79.
5. The stock has a market cap of $40.38 billion.
6. On April 11, Stryker Spine acquired SafeWire’s product portfolio.
More articles on devices:
St. Jude Medical launches Axium Neurostimulator System — 5 highlights
JRI Orthopaedics, RESTORATION develop 3D printed bioceramic implant — 4 highlights
Stryker Spine acquires SafeWire, builds on MIS presence — 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
